Literature DB >> 3154443

The Denver-Pittsburgh liver transplant series.

R D Gordon1, S Iwatsuki, A G Tzakis, C O Esquivel, S Todo, L Makowka, T E Starzl.   

Abstract

Liver transplantation is now the preferred treatment for many diseases leading to end-stage liver disease. Transplantation for cancer has been disappointing and there is a significant recurrence rate after transplantation in hepatitis B-virus carriers. Additional strategies will have to be developed if we are to improve the results of transplantation for these patients. The role of immunological factors in liver transplantation continues to reveal significant differences from their role in renal transplantation and will continue to be an interesting area of study for years to come.

Entities:  

Mesh：

Year:  1987        PMID： 3154443      PMCID： PMC2982704     

Source DB:  PubMed          Journal:  Clin Transpl        ISSN： 0890-9016


  10 in total

1.  Association of HLA Compatibility and Decreased Liver Transplant Survival.

Authors:  B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

2.  Impact of Orthoclone OKT3 on liver transplantation.

Authors:  J J Fung; B H Markus; R D Gordon; C O Esquivel; L Makowka; A Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1987-04       Impact factor: 1.066

3.  Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies.

Authors:  J Fung; M Griffin; R Duquesnoy; B Shaw; T Starzl
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

4.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

Authors:  F Kissmeyer-Nielsen; S Olsen; V P Petersen; O Fjeldborg
Journal:  Lancet       Date:  1966-09-24       Impact factor: 79.321

5.  Significance of the positive crossmatch test in kidney transplantation.

Authors:  R Patel; P I Terasaki
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

Review 6.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

7.  The antibody crossmatch in liver transplantation.

Authors:  R D Gordon; J J Fung; B Markus; I Fox; S Iwatsuki; C O Esquivel; A Tzakis; S Todo; T E Starzl
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

8.  Liver transplantation across ABO blood groups.

Authors:  R D Gordon; S Iwatsuki; C O Esquivel; A Tzakis; S Todo; T E Starzl
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

9.  Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

Authors:  J J Fung; A J Demetris; K A Porter; S Iwatsuki; R D Gordon; C O Esquivel; R Jaffe; A Tzakis; B W Shaw; T E Starzl
Journal:  Nephron       Date:  1987       Impact factor: 2.847

10.  Role of liver transplantation in cancer therapy.

Authors:  S Iwatsuki; R D Gordon; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969
  10 in total
  1 in total

1.  Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis.

Authors:  K M Abu-Elmagd; M Malinchoc; E R Dickson; J J Fung; P A Murtaugh; A L Langworthy; A J Demetris; R A Krom; D H Van Thiel; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1993-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.